Tech Center 1600 • Art Units: 1632
This examiner grants 15% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17779427 | IN VITRO CELL BASED POTENCY ASSAY | Final Rejection | Merck Sharp & Dohme LLC |
| 17607841 | MODIFIED PLURIPOTENT CELLS | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18069768 | SCALING UP MYOGENIC TISSUE: LATE PASSAGE MYOGENICITY | Non-Final OA | Upside Foods, Inc. |
| 17959809 | BIOERODIBLE LIFE SUPPORT HYDROGELS FOR THE DELIVERY OF VIABLE MITOCHONDRIA | Non-Final OA | University of Kentucky Research Foundation |
| 17635820 | METHOD FOR SCREENING ANTICANCER AGENT AND COMBINATION DRUG OF KINASE INHIBITORS FOR TREATMENT OF PANCREATIC CANCER | Final Rejection | National University Corporation Hokkaido University |
| 17895068 | CELL IDENTIFICATION METHOD | Final Rejection | National Tsing Hua University |
| 17727826 | CELL SORTING METHOD | Non-Final OA | National Tsing Hua University |
| 18263471 | METHODS FOR INCREASING VIRAL TRANSDUCTION OF CELLS | Non-Final OA | Trustees of Dartmouth College |
| 18058486 | TRANSPOSITION-BASED THERAPIES | Non-Final OA | Blue Marlin Therapeutics, Inc. |
| 17907574 | REPLICATION-DEFICIENT AVIAN ADENOVIRAL VECTORS, THEIR DESIGN AND USES | Final Rejection | Greffex, Inc. |
| 18252572 | MASS PROLIFERATION CULTURE METHOD OF NK CELLS | Non-Final OA | Da Witt KANG |
| 18027892 | CELL POPULATION PRODUCTION METHOD | Non-Final OA | GN Incorporation Co Ltd |
| 18007372 | PLATELET LYSATE DERIVED FROM AUTOLOGOUS PLATELETS | Final Rejection | RAINBOW (RAINBOW INC.) |
| 18003835 | COMPOSITIONS FOR GENOME EDITING AND METHODS OF USE THEREOF | Non-Final OA | CIBUS BIOTECHNOLOGIES, INC. |
| 18075320 | METHODS AND USES OF MEDIASTINAL PLEURA TISSUE FOR VARIOUS STENT AND OTHER MEDICAL APPLICATIONS | Non-Final OA | CVDevices, LLC |
| 18071388 | METHODS AND COMPOSITIONS FOR MAINTAINING AND EXPANDING HEMATOPOIETIC STEM CELLS | Non-Final OA | Trailhead Biosystems Inc. |
| 17928103 | METHOD FOR PREVENTING INFECTION OF A HEALTHY PERSON OR A HEALTHY ANIMAL WITH A VIRUS THAT USES ACE2 AS A RECEPTOR, BINDING INHIBITOR AND MEDICAL DEVICE | Final Rejection | DEXON PHARMACEUTICALS INC. |
| 18000030 | HYPOIMMUNOGENIC CELLS | Final Rejection | HEALIOS K.K. |
| 18048291 | ENHANCED PLACENTAL STEM CELLS AND USES THEREOF | Final Rejection | Celularity Inc. |
| 17788868 | CELL CULTURE SUBSTRATE AND MANUFACTURING METHOD THEREOF | Final Rejection | AMOLIFESCIENCE CO., LTD. |
| 17780129 | RECOMBINANT POLYPEPTIDES FOR PROGRAMMING EXTRACELLULAR VESICLES | Non-Final OA | OTTAWA HOSPITAL RESEARCH INSTITUTE |
| 17753768 | GENE THERAPY EXPRESSION SYSTEM ALLEVIATING CARDIAC TOXICITY OF FKRP | Final Rejection | UNIVERSITE D'EVRY-VAL-D'ESSONNE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy